new glp-1 receptor agonists England Journalist of Medicine published great article. Read it to learn more about the science behind medications. GLP-1 are increasingly used to treat type 2 diabetes and obesity GLP-1 Receptor Agonists: New Frontiers

Krisanapan P, Suppadungsuk S, Sanpawithayakul K, Thongprayoon C, Pattharanitima P, Tangpanithandee S, Mao MA, Miao J, Cheungpasitporn W

OZEMPIC, WEGOVY MAY BE LINKED TO STOMACH PARALYSIS AND OTHER DIGESTIVE ISSUES IN LARGE-SCALE STUDY Just as Wegovy is a higher-dose version of Ozempic to treat obesity, there is a higher-dose version of Victoza sold under the brand name Saxenda but a generic version is not yet available

If its higher than that, you should avoid it

A.BarnettA

As depicted in Table 1, multiple large-scale clinical trials are ongoing to clarify the cardiovascular efficacy and safety of GLP-1 RAs and the results have been awaited with bated breath

First, they have profound effects on appetite regulation and satiety